What is already known about this subject?
How might these results change the focus of research or clinical practice?
► In view of above association, intervention trials with vitamin D are needed in Asian Indian women with pre-diabetes to evaluate if diabetes could be prevented.
AbStrAct
Background Asian Indian women are predisposed to develop obesity, metabolic syndrome and vitamin D deficiency. Relationship of vitamin D deficiency with blood glucose levels has not been explored in Asian Indian women with pre-diabetes. Specifically, women in India are more likely to have vitamin D deficiency because many of them are confined to households and have high coverage of body part with clothes, thus they may not be exposed to sufficient sunlight. In a study in North India (Delhi), the prevalence of vitamin D deficiency was high in women, particularly those belonging to low socioeconomic status. 4 Similar results have been reported for postmenopausal women in South India. 5 It is important to note that low vitamin D levels and inadequate intake of calcium may predispose postmenopausal Indian women to bone fractures. 6 Pre-diabetes is associated with abdominal obesity, insulin resistance, non-alcoholic fatty liver disease and metabolic syndrome, and such individuals are at an increased risk for developing T2DM and cardiovascular disease. 7 A recent study in 15 states of India showed that the prevalence of pre-diabetes and T2DM was 10.3% (95% CI 10.0 to 10.6) and 7.3% (95% CI 7.0 to 7.5), respectively. 8 Specifically, pre-diabetes was more prevalent than T2DM in all states in India excluding north (Punjab) and in the northeast. Importantly, Asian Indians with pre-diabetes are at a heightened risk for conversion to T2DM as compared with British Caucasians. 9 In a previous study in North India (Delhi), we showed that the women and men had similar prevalence of diabetes (13.8% and 13.3%, respectively) but average blood glucose levels (mg/dL) were higher in women as compared with men (147.3±46.3 vs 141+46.8, respectively). 10 The relationship between vitamin D and development of pre-diabetes has not been well understood. Cross-sectional and longitudinal studies have shown inverse association between vitamin D levels and incident diabetes. 11 In Nurses' Health Study (age, 30-55 years), living in USA, after multivariate adjustments, women who consumed more than 800 IU/day of vitamin D had a 23% lower risk for developing incident T2DM compared with women who consumed less than 200 IU/day (RR 0.77, 95% CI 0.63 to 0.94; p<0.01). 12 Only a few studies have been done in India regarding insulin resistance, hyperglycemia and vitamin D deficiency. No association has been reported between vitamin D levels, body mass index (BMI), T2DM and hemoglobin A1C across the spectrum of glucose intolerance in Asian Indians residing in Western India. 13 In a cross-sectional study in East India, individuals with pre-diabetes (n, 157) were investigated for vitamin D deficiency and insulin resistance. In this study, individuals with vitamin D deficiency showed significant inverse correlation to insulin resistance and positive correlation with insulin sensitivity.
14 Further, same authors showed significantly lower levels of serum adiponectin and serum 25-hydroxy vitamin D (25(OH) D) and higher serum insulin levels in persons with pre-diabetes or T2DM as compared with controls. 15 Of note, all above studies in India involved limited number of subjects and have included individuals from both genders. In view of propensity of Indian women to have obesity, metabolic syndrome and consequent hyperglycemia and low serum 25(OH)D levels, an investigation on larger number of women at high risk for development of diabetes is required.
MeTHOds subjects
We conducted a cross-sectional population-based study approved by the institutional ethics committee. Subjects were randomly selected to have approximate representation from each income group (high-income group ~10%, middle-income group ~65%-70%, and low-income group ~15%-20%) from 35 residential locations according to the approximate proportion of individuals living in Delhi. After informed consent, fasting blood glucose (FBG) levels were done in 1361 women (20-60 years of age) from June 2012 to June 2017. Among this group, 797 women were categorized as having pre-diabetes (figure 1). Subjects who received vitamin D or calcium supplementation in the previous 6 months, any medication which could affect insulin sensitivity, vitamin D or calcium metabolism (eg, metformin, thiazolidinediones, steroids, and so on) within the last 1 month, those with pregnancy, severe end-organ damage or chronic diseases, malignancy, and known diabetes mellitus and other endocrine disorders were excluded from the study.
demographic, clinical and anthropometric measurements
Demographic and clinical profiles, medical history (personal and family), socioeconomic characteristics, skin exposure to sun and overall duration of sunlight exposure were determined with the use of prevalidated questionnaire. Skin exposure was recorded by per cent of body surface area (face/hands, face/hands and arms, and face/hands and legs) exposed to sunlight. The duration of sunlight exposure (min/day) was assessed in the following manner: <5 min, 5-15 min, 15-30 min and >30 min. Blood pressure was measured by a standard mercury sphygmomanometer, over the right arm in sitting position. Weight and height were recorded, and BMI was calculated.
Biochemical analysis FBG was analyzed as previously described. 16 Serum 25(OH)D levels were measured by chemiluminescence method (DiaSorin LIAISON 25-OH D, Stillwater, Minnesota, USA). The LIAISON 25(OH)D assay is a direct competitive chemiluminescence immunoassay for quantitative determination of total 25(OH)D in serum sample. 17 The intra-assay coefficient of variation was 1.61% and the interassay coefficient was 2.06%. statistical analysis Data were entered in an Excel spreadsheet (Microsoft, Washington, USA). The distribution of demographic, clinical, medical history (personal and family), socioeconomic and behavioral characteristics, sun and skin exposure and biochemical parameters was confirmed for approximate normality. We used mean and SD and number (%) to summarize the variables. Comparison of general characteristics, mean of variables and proportion of risk factors by serum 25(OH)D status groups including mean of serum 25(OH)D levels were performed using Fisher's exact test and non-parametric statistics such as Kruskal-Wallis tests (post hoc by Bonferroni's method). The correlation regression was calculated using Spearman's test. After adjusting for age and family income (surrogate of socioeconomic status of the family), one-way analysis of variance (ANOVA) and analysis of covariance were carried out. All statistical analyses were performed using SPSS (V.21.0, SPSS). For all above, p value of<0.05 was considered as statistically significant. Values are given as the number, %. P<0.05 is statistically significant.
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FBG levels (p=0.013) were significantly higher in subjects with vitamin D deficiency as compared with those with vitamin D insufficiency and sufficiency (table 2) .
25(OH)d levels
The prevalence (%) of vitamin D deficiency, insufficiency and sufficiency was 68.6, 25.9 and 5.5, respectively. After stratifying the sample according to serum 25(OH) D quintiles, we observed age (p=0.002) was significantly increased in the first quintile as compared with other quintiles. Further, family history of diabetes (p=0.03) was significantly higher in the second quintile as compared with other quintiles (tables 2 and 3). We did not find any significant difference of FBG values (mg/dL) between three categories of individuals to play a regulatory role in calcium flux within β cells, insulin secretion, and β cell survival. Vitamin D deficiency impairs glucose-mediated insulin secretion in rat pancreatic beta cells, while vitamin D supplementation seems to restore such glucose-stimulated insulin secretion. 21 22 Overall, these and several other studies have indicated that vitamin D may have a direct effect on β cell function mediated by binding of the circulating active form, 1,25(OH)2D, to vitamin D receptor, which is expressed in pancreatic β cells. 23 Further, activation of vitamin D occurred within the β cells by the 25(OH)D1α hydroxylase enzyme (CYP27B1), which is expressed in β cells, thereby allowing for a paracrine effect of circulating 25(OH)D. 24 Having stated that, association of low vitamin D levels with hyperglycemia in human beings continues to be researched and debated. Specifically, individuals with pre-diabetes have been less investigated in the context of vitamin D deficiency (table 5) . These data highlight some important information; first except a few, most studies have been done in limited number of subjects. Second, no investigator has specifically focused on women with pre-diabetes.
Abbasi et al 25 showed that subjects with pre-diabetes and low circulating 25(OH)D levels were most insulin resistant and had impaired β cell function as compared with normal fasting glucose-vitamin deficient and normal fasting glucose-vitamin D sufficient subgroups. In National Health and Nutrition Examination Survey 
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In a longitudinal cohort study, Deleskog et al 27 showed that high serum 25(OH)D levels predicted a reduced risk of converting to diabetes from pre-diabetes, but this was not seen in those with normal glucose tolerance.
Despite data showing widespread deficiency of vitamin D in India, its relationship with the metabolic syndrome and T2DM has not been adequately researched; some of these have been discussed in the introduction of this paper. In 2010, a 4-week pilot study showed that shortterm improvement in vitamin D levels was not associated with improvement in glucose tolerance, insulin secretion, or insulin sensitivity in 28 Asian Indian patients with moderately controlled T2DM. 28 In 2013, Dutta et al 14 showed that individuals with the lowest 25(OH)D levels (<10 ng/mL) had the highest level of insulin resistance.
Intervention trials with vitamin D in Asian Indians are fewer. In a double-blind randomized placebo controlled trial (35 in supplementation group and 36 in control group), Nagpal et al 29 showed that oral supplementation with cholecalciferol for 6 weeks improved insulin sensitivity and β cell function. In a longer open-label randomized prospective study, Dutta et al 30 showed that vitamin D supplementation in subjects with pre-diabetes led to decreased progression to diabetes and promoted reversal to normoglycemia. In a smaller (n, 36) trial in North India, vitamin D supplementation (4000 IU/day) for 6 months in vitamin D-deficient women (aged 18-35 years) with polycystic ovary syndrome did not show any significant effects on parameters of insulin sensitivity/ resistance and insulin secretion despite normalization of serum 25(OH)D levels. 31 Internationally, there have been several trials on vitamin D supplementation in individuals with pre-diabetes and diabetes. In a meta-analysis (10 randomized controlled trials) of effects of vitamin D supplementation on insulin resistance and pre-diabetes, homeostatic model assessment of insulin resistance did not show any change. However, vitamin D supplementation reduced FBG and HbA1c levels. 32 A systematic review and meta-analysis of 23 randomized controlled trials (n, 1797) showed no significant effect in change of HbA1c after vitamin D intervention as compared with placebo. However, a significant effect of vitamin D supplementation was seen on FBG in four studies with a mean baseline HbA1c ≥8%. 33 Overall, it appears that further trials are warranted with vitamin D supplementation in individuals with pre-diabetes. The 
COnClusIOn
This study shows that low serum 25(OH)D levels are associated with higher blood glucose values in Asian Indian women with pre-diabetes.
